End-stage kidney disease and rationing of kidney replacement therapy in the free state province, South Africa: a retrospective study
| dc.contributor.author | Molaoa, Thabang T | |
| dc.contributor.author | Bisiwe, Feziwe B | |
| dc.contributor.author | Ndlovu, Kwazi C | |
| dc.date.accessioned | 2021-05-20T11:07:53Z | |
| dc.date.available | 2021-05-20T11:07:53Z | |
| dc.date.issued | 2021-05-11 | |
| dc.date.updated | 2021-05-16T03:10:05Z | |
| dc.description.abstract | Abstract Background End-stage kidney disease (ESKD) and the required kidney replacement therapy (KRT) are significant public health challenges for low-and-middle-income countries. The South African government adopted a KRT rationing policy to balance the growing need for KRT and scarce resources. We aimed to describe the epidemiology and KRT access in patients with ESKD referred to the main public sector hospital in the Free State Province, South Africa. Methods A retrospective study of adult patients with ESKD admitted to Universitas Academic Hospital for KRT, was conducted between 1 January 2016 and 31 December 2018. A review of the KRT committee decisions to offer or deny KRT based on the KRT rationing policy of the Free State was undertaken. Demographic information, KRT committee outcomes, laboratory test results, and clinical details were collected from assessment tools, KRT committee meeting diaries, and electronic hospital records. Results Of 363 patients with ESKD referred for KRT access, 96 with incomplete records were excluded and 267 were included in the analysis. Median patient age was 40 (interquartile range, 33‒49) years, and male patients accounted for 56.2 % (150/267, p = 0.004) of the cohort. The average annual ESKD incidence was 49.9 (95 % confidence interval [CI], 35.8‒64.0) per-million-population. The most prevalent comorbidities were hypertension (42.3 %; 113/267), human immunodeficiency virus (HIV) (28.5 %; 76/267), and diabetes mellitus (19.1 %; 51/267). The KRT access rate was 30.7 % (82/267), with annual KRT incidence rates of 8.05 (95 % CI, 4.98‒11.1), 11.5 (95 % CI, 7.83‒15.1), and 14.1 (95 % CI, 10.3‒18.0) per-million-population in 2016, 2017, and 2018, respectively. Advanced organ dysfunction was the commonest reason recorded for KRT access denial (58.9 %; 109/185). Age (odds ratio [OR], 1.04; 95 % CI, 1.00‒1.07; p = 0.024) and diabetes (OR, 5.04; CI, 1.69‒15.03; p = 0.004) were independent predictors for exclusion from KRT, while hypertension (OR, 1.80; 1.06‒3.04; p = 0.029) independently predicted advanced organ dysfunction resulting in KRT exclusion. Conclusions Non-communicable and communicable diseases, including hypertension, diabetes, and HIV, contributed to ESKD, highlighting the need for improved early prevention strategies to address a growing incidence rate. Two-thirds of ESKD patients were unable to access KRT, with age, diabetes mellitus, and advanced organ dysfunction being significant factors adversely affecting KRT access. | |
| dc.identifier.citation | BMC Nephrology. 2021 May 11;22(1):174 | |
| dc.identifier.ris | TY - AU - Molaoa, Thabang T AU - Bisiwe, Feziwe B AU - Ndlovu, Kwazi C AB - Abstract Background End-stage kidney disease (ESKD) and the required kidney replacement therapy (KRT) are significant public health challenges for low-and-middle-income countries. The South African government adopted a KRT rationing policy to balance the growing need for KRT and scarce resources. We aimed to describe the epidemiology and KRT access in patients with ESKD referred to the main public sector hospital in the Free State Province, South Africa. Methods A retrospective study of adult patients with ESKD admitted to Universitas Academic Hospital for KRT, was conducted between 1 January 2016 and 31 December 2018. A review of the KRT committee decisions to offer or deny KRT based on the KRT rationing policy of the Free State was undertaken. Demographic information, KRT committee outcomes, laboratory test results, and clinical details were collected from assessment tools, KRT committee meeting diaries, and electronic hospital records. Results Of 363 patients with ESKD referred for KRT access, 96 with incomplete records were excluded and 267 were included in the analysis. Median patient age was 40 (interquartile range, 33‒49) years, and male patients accounted for 56.2 % (150/267, p = 0.004) of the cohort. The average annual ESKD incidence was 49.9 (95 % confidence interval [CI], 35.8‒64.0) per-million-population. The most prevalent comorbidities were hypertension (42.3 %; 113/267), human immunodeficiency virus (HIV) (28.5 %; 76/267), and diabetes mellitus (19.1 %; 51/267). The KRT access rate was 30.7 % (82/267), with annual KRT incidence rates of 8.05 (95 % CI, 4.98‒11.1), 11.5 (95 % CI, 7.83‒15.1), and 14.1 (95 % CI, 10.3‒18.0) per-million-population in 2016, 2017, and 2018, respectively. Advanced organ dysfunction was the commonest reason recorded for KRT access denial (58.9 %; 109/185). Age (odds ratio [OR], 1.04; 95 % CI, 1.00‒1.07; p = 0.024) and diabetes (OR, 5.04; CI, 1.69‒15.03; p = 0.004) were independent predictors for exclusion from KRT, while hypertension (OR, 1.80; 1.06‒3.04; p = 0.029) independently predicted advanced organ dysfunction resulting in KRT exclusion. Conclusions Non-communicable and communicable diseases, including hypertension, diabetes, and HIV, contributed to ESKD, highlighting the need for improved early prevention strategies to address a growing incidence rate. Two-thirds of ESKD patients were unable to access KRT, with age, diabetes mellitus, and advanced organ dysfunction being significant factors adversely affecting KRT access. DA - 2021-05-11 DB - OpenUCT DP - University of Cape Town KW - Incidence rate KW - End-stage kidney disease KW - Kidney replacement therapy KW - Dialysis access KW - South Africa LK - https://open.uct.ac.za PY - 2021 T1 - End-stage kidney disease and rationing of kidney replacement therapy in the free state province, South Africa: a retrospective study TI - End-stage kidney disease and rationing of kidney replacement therapy in the free state province, South Africa: a retrospective study UR - http://hdl.handle.net/11427/33241 ER - | en_ZA |
| dc.identifier.uri | https://doi.org/10.1186/s12882-021-02387-x | |
| dc.identifier.uri | http://hdl.handle.net/11427/33241 | |
| dc.language.rfc3066 | en | |
| dc.rights.holder | The Author(s) | |
| dc.source.journalvolume | 22 | |
| dc.source.uri | https://bmcnephrol.biomedcentral.com/ | |
| dc.subject | Incidence rate | |
| dc.subject | End-stage kidney disease | |
| dc.subject | Kidney replacement therapy | |
| dc.subject | Dialysis access | |
| dc.subject | South Africa | |
| dc.title | End-stage kidney disease and rationing of kidney replacement therapy in the free state province, South Africa: a retrospective study |